Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Fang Hui"'
Autor:
Cai-Feng Su, Shaung Zhao, Richard Muwonge, Qin-Jing Pan, Rengaswamy Sankaranarayanan, Li-Jun Du, Fang-Hui Zhao, Partha Basu, Xian-Zhi Duan, You-Lin Qiao, Shang-Ying Hu, Xun Zhang, Xuelian Zhao, Xi-E Xiang, Zhihua Liu
Publikováno v:
International Journal of Cancer. 148:1419-1427
Thermal ablation is a point-of-care ablative treatment technique for cervical intraepithelial neoplasia (CIN). However, limited information is available about its efficacy in low- and middle-income countries. We evaluated the efficacy of thermal abla
Autor:
Fang-Hui Zhao, Jun-Fei Ma, Shang-Ying Hu, Xun Zhang, Remila Rezhake, Feng Chen, Qin-Jing Pan, You-Lin Qiao
Publikováno v:
Gynecologic Oncology. 156:616-623
Objective To estimate long-term outcomes of biopsy-confirmed cervical intraepithelial neoplasia grade 1 (CIN1) or normal cervix and identify the cofactors during disease progression. Methods In 1999, a cervical cancer screening cohort in Shanxi, Chin
Autor:
Changfa Xia, Remila Rezhake, Xiaoqian Xu, Shang-Ying Hu, Yan Wang, Xun Zhang, Rengaswamy Sankaranarayanan, Xuelian Zhao, You-Lin Qiao, Xian-Zhi Duan, Fang-Hui Zhao, Partha Basu
Publikováno v:
International Journal of Cancer. 147:1275-1285
Human papillomavirus (HPV) test, self-sampling and thermal ablation for cervical intraepithelial neoplasia (CIN) have been developed separately to increase screening coverage and treatment compliance of cervical cancer screening programmes. A large-s
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 374-384 (2020)
Cancer Medicine
Cancer Medicine
Background Human papillomavirus (HPV) attributable cancer burden is currently unknown in China, which is essential to evaluate the potential benefit of existing HPV https://www.sciencedirect.com/topics/medicine-and-dentistry/vaccine and to inform can
Autor:
Fengcai Zhu, Qin-Jing Pan, Jia-Xi Yu, Frank Struyf, Ying Hong, Yunkun He, Shang-Ying Hu, Naveen Karkada, Yuemei Hu, Yi-Ju Zhang, Yan-Shu Zhang, Xiaoping Yang, Haiwen Tang, Cheng-Fu Zhang, Feng Chen, P.V. Suryakiran, Dan Bi, Jun Bi, Changrong Wang, Fang-Hui Zhao, Xun Zhang, Lingling Shen, Qian Zhang, Hong Wang, Shiyin Xue, Wen-hua Zhang, Jiahong Zhu, Yejiang Zhu
Publikováno v:
Cancer Medicine, Vol 8, Iss 14, Pp 6195-6211 (2019)
Cancer Medicine
Cancer Medicine
Background Cervical cancer is a major public health concern in China. We report the end‐of‐study results of a phase II/III trial to assess the efficacy, immunogenicity, and safety of the AS04‐human papillomavirus (HPV)‐16/18 vaccine in Chines
Autor:
Ying Hong, Mei Li, Jun Zhao, Ningshao Xia, Xuelian Cui, Xin Wu, Meng Guo, Shaowei Li, Bin Zhao, Fang-Hui Zhao, Wen Chen, Hui Zhao, Yingying Su, Yun-Fei Jiang, Ba-Yi Li, Juan Li, Wen-hua Zhang, Fengxian Zheng, Wen-Yu Liu, Junzhi Wang, Jun Zhang, Cui-Hong Dai, Yanping Li, Shoujie Huang, Huirong Pan, Chao Zhao, Xun Zhang, Ting Wu, Jie Tang, Lihui Wei, Li-Dong Ke, Dong-Ping Guo, Changgui Li, You-Lin Qiao, Zhijie Lin, Yimin Li, Kai Chu, Rong-Cheng Li, Caihong Li, Yuemei Hu, Fengcai Zhu, Guo-Qi Gao, Qin-Jing Pan, Mingqiang Li, Qing Li
Publikováno v:
J Natl Cancer Inst
Background The high cost and insufficient supply of human papillomavirus (HPV) vaccines have slowed the pace of controlling cervical cancer. A phase III clinical trial was conducted to evaluate the efficacy, safety, and immunogenicity of a novel Esch
Autor:
Le Li, Hongyun Zhang, Xiaoqian Xu, Gary M. Clifford, Fang-Hui Zhao, Rufei Duan, Chongxi Li, Aihui Wu, You-Lin Qiao
Publikováno v:
Sexually transmitted infections. 98(4)
ObjectivesTo explore the prevalence and risk factors of anogenital human papillomavirus (HPV) infection and neoplasia among women living with HIV (WLHIV) in China.MethodsA cross-sectional survey was conducted from 2019 to 2020, 409 WLHIV aged 18 year
Autor:
Karen Canfell, Maribel Almonte, E. Peeters, Chris J.L.M. Meijer, Jesper Bonde, Kate Cuschieri, Peter Hillemanns, Marc Arbyn, Nicolas Wentzensen, Joakim Dillner, Marie Simon, Anja Ostrbenk Vanlencak, Remila Rezhake, Fang-Hui Zhao, Johannes Berkhof, Mario Poljak, Silvia de Sanjosé, Lan Xu, Murat Gultekin
Publikováno v:
Arbyn, M, Simon, M, Peeters, E, Xu, L, Meijer, C J L M, Berkhof, J, Cuschieri, K, Bonde, J, Ostrbenk Vanlencak, A, Zhao, F-H, Rezhake, R, Gultekin, M, Dillner, J, de Sanjosé, S, Canfell, K, Hillemanns, P, Almonte, M, Wentzensen, N & Poljak, M 2021, ' 2020 list of human papillomavirus assays suitable for primary cervical cancer screening ', Clinical Microbiology and Infection, vol. 27, no. 8, pp. 1083-1095 . https://doi.org/10.1016/j.cmi.2021.04.031
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
Background Only clinically validated HPV assays can be accepted in cervical cancer screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 international validation criteria (Meijer-2009). Data Sources PubMed/Medline, Emb
Autor:
Ying Hong, Haiwen Tang, Fengcai Zhu, Shang-Ying Hu, Qin-Jing Pan, Cheng-Fu Zhang, Yuemei Hu, Xiaoping Yang, Xiaoqian Xu, Feng Chen, Fang-Hui Zhao, Dan Bi, Jia-Xi Yu, Shuang Zhao, Wen-hua Zhang, Jiahong Zhu, Yejiang Zhu, Xun Zhang, Frank Struyf, Naveen Karkada
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Human papillomavirus (HPV) vaccines are efficacious against HPV infections and associated lesions in women HPV-naïve at vaccination. However, vaccine efficacy (VE) against oncogenic, high-risk HPV (HR-HPV) types in women infected with any other HR-H
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Background It is widely acknowledged that HPV prophylactic vaccine could prevent new infections and their associated lesions among women who are predominantly HPV-naive at vaccination. Yet there still remains uncertainty about whether HPV vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0bf2dfc0101843b745d16d264f4c0b1
https://doi.org/10.21203/rs.3.rs-34996/v2
https://doi.org/10.21203/rs.3.rs-34996/v2